Innovative Medicines Canada Private Market Policy Summit – Drug Pricing & Reimbursement

As an industry expert, was invited by IMC to join Advisory colleagues to discuss Drug Plan management and the impact to our private payor clients.

Insights

More Related Articles

Human Capital Benefits Benchmarking Tool – Coming Soon

Canadian Leadership Council on Drug Plan Partnerships

Canadian Insurer details on coverage for Wegovy for cardiovascular treatment